CellaVision AB (publ)

OM:CEVI Stock Report

Market Cap: SEK 6.0b

CellaVision Valuation

Is CEVI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CEVI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CEVI (SEK250.5) is trading below our estimate of fair value (SEK307.57)

Significantly Below Fair Value: CEVI is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CEVI?

Other financial metrics that can be useful for relative valuation.

CEVI key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue8.3x
Enterprise Value/EBITDA29x
PEG Ratio1.8x

Price to Earnings Ratio vs Peers

How does CEVI's PE Ratio compare to its peers?

The above table shows the PE ratio for CEVI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average44.2x
ELOS B Elos Medtech
104.3xn/aSEK 5.7b
ARJO B Arjo
22.4x20.9%SEK 11.2b
SUS Surgical Science Sweden
30.7x27.0%SEK 6.4b
EKTA B Elekta
19.4x14.4%SEK 25.3b
CEVI CellaVision
42.3x24.0%SEK 6.0b

Price-To-Earnings vs Peers: CEVI is good value based on its Price-To-Earnings Ratio (42.3x) compared to the peer average (44.2x).

Price to Earnings Ratio vs Industry

How does CEVI's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a25.1%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a25.1%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: CEVI is expensive based on its Price-To-Earnings Ratio (42.3x) compared to the European Medical Equipment industry average (30.1x).

Price to Earnings Ratio vs Fair Ratio

What is CEVI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CEVI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio42.3x
Fair PE Ratio25.7x

Price-To-Earnings vs Fair Ratio: CEVI is expensive based on its Price-To-Earnings Ratio (42.3x) compared to the estimated Fair Price-To-Earnings Ratio (25.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CEVI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 250.50
SEK 256.25
+2.3%
10.0%SEK 300.00SEK 235.00n/a4
Jun ’25SEK 262.00
SEK 257.50
-1.7%
9.6%SEK 300.00SEK 240.00n/a4
May ’25SEK 225.50
SEK 257.50
+14.2%
9.6%SEK 300.00SEK 240.00n/a4
Apr ’25SEK 239.00
SEK 256.25
+7.2%
9.9%SEK 300.00SEK 240.00n/a4
Mar ’25SEK 256.00
SEK 256.25
+0.1%
9.9%SEK 300.00SEK 240.00n/a4
Feb ’25SEK 206.50
SEK 204.25
-1.1%
12.3%SEK 230.00SEK 165.00n/a4
Jan ’25SEK 212.00
SEK 191.75
-9.6%
11.2%SEK 222.00SEK 165.00n/a4
Dec ’24SEK 176.40
SEK 191.75
+8.7%
11.2%SEK 222.00SEK 165.00n/a4
Nov ’24SEK 139.80
SEK 200.50
+43.4%
7.4%SEK 222.00SEK 180.00n/a4
Oct ’24SEK 153.60
SEK 220.00
+43.2%
8.5%SEK 250.00SEK 200.00n/a4
Sep ’24SEK 198.00
SEK 220.00
+11.1%
8.5%SEK 250.00SEK 200.00n/a4
Aug ’24SEK 218.50
SEK 220.00
+0.7%
8.5%SEK 250.00SEK 200.00n/a4
Jul ’24SEK 183.60
SEK 197.50
+7.6%
11.9%SEK 220.00SEK 165.00n/a4
Jun ’24SEK 188.80
SEK 197.50
+4.6%
11.9%SEK 220.00SEK 165.00SEK 262.004
May ’24SEK 175.00
SEK 222.50
+27.1%
20.1%SEK 280.00SEK 160.00SEK 225.504
Apr ’24SEK 185.00
SEK 247.50
+33.8%
11.1%SEK 280.00SEK 205.00SEK 239.004
Mar ’24SEK 201.50
SEK 250.00
+24.1%
9.5%SEK 280.00SEK 215.00SEK 256.004
Feb ’24SEK 252.50
SEK 260.00
+3.0%
4.7%SEK 275.00SEK 245.00SEK 206.503
Jan ’24SEK 229.00
SEK 260.00
+13.5%
4.7%SEK 275.00SEK 245.00SEK 212.003
Dec ’23SEK 225.50
SEK 252.50
+12.0%
3.0%SEK 260.00SEK 245.00SEK 176.402
Nov ’23SEK 204.50
SEK 252.50
+23.5%
3.0%SEK 260.00SEK 245.00SEK 139.802
Oct ’23SEK 254.50
SEK 307.50
+20.8%
8.9%SEK 335.00SEK 280.00SEK 153.602
Sep ’23SEK 323.50
SEK 360.00
+11.3%
6.9%SEK 385.00SEK 335.00SEK 198.002
Aug ’23SEK 357.00
SEK 357.50
+0.1%
7.7%SEK 385.00SEK 330.00SEK 218.502
Jul ’23SEK 352.50
SEK 337.50
-4.3%
9.6%SEK 370.00SEK 305.00SEK 183.602
Jun ’23SEK 342.00
SEK 337.50
-1.3%
9.6%SEK 370.00SEK 305.00SEK 188.802

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.